VENSITY Trademark

Trademark Overview

On Wednesday, March 22, 2023, a trademark application was filed for VENSITY with the United States Patent and Trademark Office. The USPTO has given the VENSITY trademark a serial number of 97851989. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 2, 2024. This trademark is owned by Radius Health, Inc.. The VENSITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-re...
vensity

General Information

Serial Number97851989
Word MarkVENSITY
Filing DateWednesday, March 22, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateMonday, March 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRadius Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameRadius Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 16, 2023ASSIGNED TO EXAMINER
Monday, March 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 25, 2023NEW APPLICATION ENTERED

Related Keywords

vensity diseases pharmaceutical preparations treatment disorders tissue blood dermatological autoimmune gastroenterological